Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease

Journal of Neurochemistry

Volumn 72, Issue 4, 1999, Pages 1600-1608

  Sáez Valero, Javier ^a   Sberna, Gian ^a   McLean, Catriona A ^a   Small, David H ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Acetylcholinesterase; Alzheimer's disease; CSF; Glycosylation; Lectin binding

Indexed keywords

ACETYLCHOLINESTERASE; CONCANAVALIN A; ISOENZYME; WHEAT GERM AGGLUTININ;

ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; CEREBELLUM; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME BINDING; ENZYME GLYCOSYLATION; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; LECTIN BINDING; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CEREBELLUM; FRONTAL LOBE; GLYCOSYLATION; HUMANS; ISOENZYMES; LECTINS; PROTEIN BINDING;

TRITICUM AESTIVUM;

EID: 0345390947     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.721600.x     Document Type: Article

References (63)

1. Appleyard M. E., Smith A. D., Wilcock G. K., and Esiri M. M. (1983) Decreased CSF acetylcholinesterase activity in Alzheimer's disease. Lancet 2, 452.
2. Arendt T., Bruckner M. K., Lange M., and Bigl V. (1992) Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development - study of molecular forms. Neurochem. Int. 21, 381-396.
3. Atack J. R., Perry E. K., Bonham J. R., Perry R. H., Tomlinson B. E., Blessed G., and Fairbairn A. (1983) Molecular forms of acetylcholinesterase in senile dementia of Alzheimer's type, selective loss of the intermediate (10S) form. Neurosci. Lett. 40, 199-204.
4. Atack J. R., Perry E. K., Bonham J. R., Candy J. M., and Perry R. H. (1986) Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J. Neurochem. 47, 263-277.
5. Atack J. R., Perry E. K., Bonham J. R., and Perry R. H. (1987) Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid. J. Neurochem. 48, 1845-1850.
6. Atack J. R., May C., Kaye J. A., Kay A. D., and Rapoport S. I. (1988) Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type. Ann. Neurol. 23, 161-167.
7. Blass J. P., Blennow K., Delacourte A., Frisoni G. B., Jefferies W. A., McRae A., Wisniewski H. M., Parshad R., Scinto L. F. M., Scheltens P., Riekkinen P. J., Swanwick G. R. J., Wahlund L.-O., Trojanowski J. Q., Winblad B., Ihara Y., et al. (1998) Consensus report of the Working Group on: "molecular and biochemical markers of Alzheimer's disease." Neurobiol. Aging 19, 109-116.
8. Davies C. A., Mann D. M. A., Sumpter P. Q., and Yates P. O. (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J. Neurol. Sci. 78, 151-164.
9. Eckenstein F. and Sofroniew M. V. (1983) Identification of central cholinergic neurons containing both choline acetyltransferase and acetylcholinesterase and of central neurons containing only acetylcholinesterase. J. Neurosci. 3, 2286-2291.
10. Elgavish S. and Shaanan B. (1997) Lectin-carbohydrate interactions: different folds, common recognition principles. Trends Biochem. Sci. 22, 462-467.
11. Fishman E. B., Siek G. C., MacCallum R. D., Bird E. D., Volicer L., and Marquis J. K. (1986) Distribution of the molecular forms of acetylcholinesterase in human brain, alterations in dementia of the Alzheimer type. Ann. Neurol. 19, 246-252.
12. Friede R. L. (1965) Enzyme histochemical studies of senile plaques. J. Neuropathol. Exp. Neurol. 24, 477-491.
13. Geula C. and Mesulam M.-M. (1989) Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. Brain Res. 498, 185-189.
14. Grassi J., Vigny M., and Massoulié J. (1982) Molecular forms of acetylcholinesterase in bovine caudate nucleus and superior cervical ganglion: solubility properties and Hydrophobiv character. J. Neurochem. 38, 457-469.
15. Guillozet A. L., Smiley J., Mash D. C. and Mesulam M.-M. (1997) Butyrylcholinesterase in the life cycle of amyloid plaques. Ann. Neurol. 42, 909-918.
16. Hammond P., Rao R., Koenigsberger C., and Brimijoin S. (1994) Regional variation in expression of acetylcholinesterase mRNA in adult rat brain analyzed by in situ hybridization. Proc. Natl. Acad. Sci. USA 91, 10933-10937.
17. Inestrosa N. C. Alvarez A., Perez C. A., Moreno R. D., Vincente M., Linker C., Casanueva O. I., Soto C., and Garrido J. (1996a) Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils - possible role of the peripheral sites of the enzyme. Neuron 16, 881-891.
18. Inestrosa N. C., Alvarez A., and Calderon F. (1996b) Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid beta-peptide into Alzheimer's filaments. Mol. Psychiatry 1, 359-361.
19. Kang J., Lemaire H.-G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K.-H., Multhaup G., Beyreuther K., and Müller-Hill B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
20. Kaufer D., Friedman A., Seidman S., and Soreq H. (1998) Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393, 373-377.
21. Koelle G. B. and Friendenwald J. S. (1949) A histochemical method for localizing cholinesterase activity. Proc. Soc. Exp. Biol. Med. 70, 617-622.
22. Landwehrmeyer B., Probst A., Palacios J. M., and Mengod G. (1993) Expression of acetylcholinesterase messenger RNA in human brain: an in situ hybridization study. Neuroscience 57, 615-634.
23. Liao J., Heider H., Sun M.-C., and Brodheck U. (1992) Different glycosylation in acetylcholinesterases from mammalian brain and erythrocytes. J. Neurochem. 58, 1230-1238.
24. Lis H. and Sharon N. (1986) Lectins as molecules and as tools. Annu. Rev. Biochem. 55, 35-67.
25. Luo Z., Fuentes M.-E., and Taylor P. (1994) Regulation of acetylcholinesterase mRNA stability by calcium during differentiation from myoblasts to myotubes. J. Biol. Chem. 269, 27216-27223.
26. Mann D. M. A., Iwatsubo T., and Snowden J. S. (1996) Atypical amyloid (Aβ) deposition in the cerebellum in Alzheimer's disease: an immunohistochemical study using end-specific Aβ monoclonal antibodies. Acta Neuropathol. (Berl.) 91, 647-653.
27. Massoulié J. and Bon S. (1982) The molecular forms of cholinesterase and acetylcholinesterase in vertebrates. Annu. Rev. Neurosci. 5, 57-106.
28. Massoulié J., Pezzementi L., Bon S., Krejci E., and Valletta F.-M. (1993) Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41, 31-91.
29. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
30. Méflah K., Bernard S., and Massoulié J. (1984) Interactions with leclins indicate differences in the carbohydrate composition of the membrane-bound enzymes acetylcholinesterase and 5′-nucleotidase in different cell types. Biochimie 66, 59-69.
31. Mesulam M.-M., Geula C., and Morán M. A. (1987) Anatomy of cholinesterase inhibition of Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Ann. Neurol. 22, 683-691.
32. Mesulam M.-M., Geula C., Cosgrove R., Mash D., and Brimijoin S. (1991) Immunohistochemical demonstration of axonal and perikaryal acetylcholinesterase in human cerebral cortex. Brain Res. 539, 233-238.
33. Michaelson S. and Small D. H. (1993) A protease is recovered with a dimeric form of acetylcholinesterase in fetal bovine serum. Brain Res. 611, 75-80.
34. Mirra S. S., Gearing M., McKeel D. W. Jr., Crain B. J., Hughes J. P., Vanbelle G., Heyman A., Ball M. J., Clark A. W., Hansen L. A., Hedreen J. C., Joachim C. L., Kim R. C., Kirkpatrick J. B., Markesbery W. R., David D., Martínez A. J., Miller C. A., Moossy J., Morris J., Nochlin D., Perl D. P., Purohit D., Petito C. K., Rao G. R., et al. (1994) Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry of Alzheimer's Disease. Neuropathol. Exp. Neurol. 53, 303-315.
35. Moral-Naranjo M. T., Cabezas-Herrera J., and Vidal C. J. (1996) Molecular forms of acetyl- and butyrylcholinesterase in normal and dystrophic mouse brain. J. Neurosci. Res. 43, 224-234.
36. Moran M. A., Mufson E. J., and Gómez-Ramos P. (1993) Colocalization of cholinesterases with β amyloid protein in aged and Alzheimer's brains. Acta Neuropathol. (Berl.). 85, 362-369.
37. 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann. Neurol. 38, 643-648.
38. Navaratnam D. S., Priddle J. D., McDonald B., Esiri M. M., Robinson J. R., and Smith A. D. (1991) Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer's disease. Lancet 337, 447-450.
39. Pfeffer R. I., Afifi A. A., and Chance J. M. (1987) Prevalence of Alzheimer's disease in a retirement community. Am. J. Epidemiol. 125, 420-436.
40. Probst A., Langui D., and Ulrich J. (1991) Alzheimer's disease: a description of the structural lesions. Brain Pathol. 1, 229-239.
41. Sáez-Valero J., Tornel P. L. Muñoz-Delgado E., and Vidal C. J. (1993) Amphiphilic and hydrophilic forms of acetyl- and butyrylcholinesterase in human brain. J. Neurosci. Res. 35, 678-689.
42. Saéz-Valero J., Sberna G., McLean C., Masters C. L., and Small D. H. (1997) Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease. Lancet 350, 929.
43. Saxena A., Raveh L., Ashani Y., and Doctor B. P. (1997) Structure of glycan moieties responsible for the extended circulatory life time of fetal bovine serum acetylcholinesterase and equine serum butyrylcholinesterase. Biochemistry 36, 7481-7489.
44. Saxena A., Ashani Y., Raveh L., Stevenson D., Patel T., and Doctor B. P. (1998) Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases. Mol. Pharmacol. 53, 112-122.
45. Sberna G., Sáez-Valero J., Beyreuther K., Masters C. L., and Small D. H. (1997) The amyloid β-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J. Neurochem. 69, 1177-1184.
46. Sberna G., Sáez-Valero J., Li Q.-X., Czech C. Beyreuther K., Masters C. L., McLean C. A., and Small D. H. (1998) Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the β-amyloid protein precursor of Alzheimer's disease. J. Neurochem. 71, 723-731.
47. Schegg K. M., Harrington L. S., Neilsen S., Zweig R. M., and Peacock J. H. (1992) Soluble and membrane-bound forms of brain acetylcholinesterase in Alzheimer's disease. Neurobiol. Aging 13, 697-704.
48. Schoenberg B. S., Kokmen E., and Okazaki H. (1987) Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann. Neurol. 22, 724-729.
49. Seidman S., Sternfeld M. Benazizaloya R., Timberg R., Kaufernachum D., and Soreq H. (1995) Synaptic and epidermal accumulation of human acetylcholinesterase is encoded by alternative 3′-terminal exons. Mol Cell. Biol. 15, 2993-3002.
50. Shen Z.-X. (1997) An CSF anomalous molecular form of acetylcholinesterase in demented and non-demented subject. Neuroreport 8, 3229-3232.
51. Shen Z.-X. and Zhang Z. (1993) Anomalous acetylcholinesterase in CSF without clinical diagnosis of Alzheimer's disease. Lancet 342, 62.
52. Siek G. C., Katz L. S., Fishman E. B., Korosi T. S., and Marquis J. K. (1990) Molecular forms of acetylcholinesterase in subcortical areas of normal and Alzheimer disease brain. Biol. Psychiatry 27, 573-580.
53. Silman I., Lyles J. M., and Barnard E. A. (1978) Intrinsic forms of acetylcholinesterase in skeletal muscle. FEBS Lett. 94, 166-170.
54. Small D. H., Michaelson S., and Sberna G. (1996) Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. 28, 453-483.
55. Smith A. D., Jobst K. A., Navaratnam D. S., Shen Z.-X. Priddle J. D., McDonald B., King E., and Esiri M. M. (1991) Anomalous acetylcholinesterase in lumbar CSF in Alzheimer's disease, Lancet 338, 1538.
56. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M., D., Fujimoto E. K., Goeke N. M., Olson B. J., and Klenk D. C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
57. Soreq H., Ben-Aziz R., Prody C. A., Seidman S., Gnatt A., Neville L., Lieman-Hurwitz J., Lev-Lehman E., Ginzberg D., Lapidot-Lifson Y., and Zakut H. (1990) Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G+C-rich attenuating structure. Proc. Natl. Acad. Sci. USA 87, 9688-9692.
58. Treskatis S., Ebert C., and Layer P. G. (1992) Butyrylcholinesterase from chicken brain is smaller than that from serum: its purification, glycosylation, and membrane association. J. Neurochem. 58, 2236-2247.
59. Turner G. A. (1992) N-Glycosylation of serum proteins in disease and its investigation using lectins. Clin. Chim. Acta 208, 149-171.
60. Ulrich J., Meier-Ruge W., Probst A., Meier E., and Ipsen S. (1990) Senile plaques, staining for acetylcholinesterase and A4 protein: a comparative study in the hippocampus and entorhinal cortex. Acta Neuropathol. (Berl.) 80, 624-628.
61. Vidal C. J. (1996) Glycosylation of cholinesterases and its alteration in some pathological states. Recent Res. Dev. Neurochem. 1, 37-54.
62. Wright C. I., Geula C., and Mesulam M.-M. (1993) Neuroglial cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles and patterns of selective vulnerability. Ann. Neurol. 34, 373-384.
63. Younkin S. G., Goodridge B., Katz J., Lockett G., Nafziger D., Usiak M. F., and Younkin L. H. (1986) Molecular forms of acetylcholinesterase in Alzheimer's disease. Fed Proc. 45, 2982-2988.